Cargando…
Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies
Glioblastoma is the most common and aggressive malignant tumor of the central nervous system. Despite the existing high unmet medical needs, the past few decades have seen no notable improvement in overall survival for glioblastoma patients. One active area of research to develop new therapeutic opt...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730539/ https://www.ncbi.nlm.nih.gov/pubmed/31564969 http://dx.doi.org/10.2147/CMAR.S216675 |